Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial.
Rerks-Ngarm, Supachai 1 , a; Pitisuttithum, Punnee 2 , a; Excler, Jean-Louis 4 , 5 , c; Nitayaphan, Sorachai 3; Kaewkungwal, Jaranit 2; Premsri, Nakorn 1; Kunasol, Prayura 1; Karasavvas, Nicos 3; Schuetz, Alexandra 3 , 4 , 5; Ngauy, Viseth 3 , d; Sinangil, Faruk 7; Dawson, Peter 6; deCamp, Allan C. 8; Phogat, Sanjay 9; Garunathan, Sanjay 9; Tartaglia, James 9; DiazGranados, Carlos 9; Ratto-Kim, Silvia 4 , e; Pegu, Poonam 4 , 5; Eller, Michael 4 , 5; Karnasuta, Chitraporn 3; Montefiori, David C. 10 , 11; Sawant, Sheetal 10; Vandergrift, Nathan 10; Wills, Saintedym 10; Tomaras, Georgia D. 10; Robb, Merlin L. 4 , 5; Michael, Nelson L. 4; Kim, Jerome H. 4 , c; Vasan, Sandhya 3 , 4 , 5 , b; O'Connell, Robert J. 3 , 4 , b; for the RV305 Study Team
[Article]
Journal of Infectious Diseases.
215(8):1255-1263, April 15, 2017.
(Format: HTML, PDF)